8-K

T3 Defense Inc. (DFNS)

8-K 2023-07-06 For: 2023-06-30
View Original
Added on April 05, 2026

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June30, 2023

BRILLIANT ACQUISITION CORPORATION

(Exact name of registrant as specified in its charter)

British Virgin Islands 001-39341 N/A
(State or other jurisdiction<br><br>of incorporation) (Commission File Number) (IRS Employer<br><br>Identification No.)

99 Dan Ba Road, C-9, Putuo District,

Shanghai, Peoples Republic of China

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code:

(86) 021-80125497

Not Applicable(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written<br>communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting<br>material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement<br>communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement<br>communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant BRLIU The Nasdaq Stock Market LLC
Ordinary Shares, no par value per share BRLI The Nasdaq Stock Market LLC
Rights, each right entitling the holder to 1/10 of one Ordinary Share BRLIR The Nasdaq Stock Market LLC
Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share BRLIW The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting orFailure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On June 30, 2023, Brilliant Acquisition Corporation, a British Virgin Islands company (“Brilliant” or the “Company”) received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, the Company’s failure to maintain a minimum Market Value of Listed Securities (MVLS) of $35 million served as an additional basis for delisting of the Company’s securities (units, ordinary shares, warrants, and rights) unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”). Previously, on June 27, 2023, Brilliant received a notice from the staff of Nasdaq indicating that the Company’s securities would be subject to suspension and delisting from The Nasdaq Capital Market at the opening of business on July 7, 2023 due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement.

If Brilliant did not request a hearing, Brilliant’s securities would have been suspended from The Nasdaq Capital Market at the opening of business on July 7, 2023. The Company requested a hearing on July 3, 2023, and such request resulted in a stay of any suspension or delisting action pending the hearing.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRILLIANT ACQUISITION CORPORATION
By: /s/ Dr. Peng Jiang
Name: Dr. Peng Jiang
Title: Chief Executive Officer
Dated: July 5, 2023

2